BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Business

  Symbiosis Release: Scottish CMO Opens U.S. Office

  February 13, 2017

   · 

  2 min read
• Drug Development

  TRANSGENE And Léon Bérard Cancer Center Announce Dosing Of The First Patient In A Phase 1 Immunotherapy Clinical Trial Evaluating The Intra-Tumoral Co-Administration Of Pexa-Vec Plus Ipilimumab (Yervoy) In Solid Cancers

  February 13, 2017

   · 

  5 min read
• BioMidwest

  Bioventus Raises $10,000 For Opportunity Village

  February 13, 2017

   · 

  3 min read
• Pharm Country

  NanoViricides, Inc. Reports The Company’s Director Dr. Boniuk Converted Series B Debenture To Equity Effectively Raising $5 Million In New Equity For The Company

  February 13, 2017

   · 

  4 min read
• Genetown

  DePuy Synthes Launches ViviGen Formable Cellular Bone Matrix, Providing A New Cellular Allograft With Alternative Consistency For Spinal Fusion Surgery

  February 13, 2017

   · 

  2 min read
• Biotech Bay

  NEMUS Bioscience Reports Favorable Bio-Distribution And Anti-Addictive Findings Versus Plant-Derived Cannabidiol (CBD) In Animal Model Studies Of NB2111, An Analogue Of Cannabidiol

  February 13, 2017

   · 

  6 min read
• Adocia To Present At The Leerink Partners 6th Annual Global Healthcare Conference

  February 13, 2017

   · 

  1 min read
• Drug Development

  ASLAN Announces First Patient Enrolled In Phase l Study Of Varlitinib In Japan

  February 13, 2017

   · 

  1 min read
• Medtronic Expands Coronary Portfolio To Include New Dxterity Diagnostic Catheters And Suite Of Tools For The Transradial Approach

  February 13, 2017

   · 

  4 min read
• Business

  APR Applied Pharma Research S.A. And Aghraas-Cigalah Announce The First Distribution Agreement Of The Innovative Solution To Treat Chronic Wounds, Nexodyn® AOS, In Middle East Markets

  February 13, 2017

   · 

  4 min read